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Background and purpose: 
Studies in animal models have suggestedsuggest that inflammation is a major contributor to 
secondary injury after intracerebral haemorrhage (ICH). Direct, non-invasive monitoring of 
inflammation in the human brain after ICH will facilitate early-phase development of anti-
inflammatory treatments. We sought to investigate the feasibility of multi-modality brain 
imaging in subacute ICH. 
 
Methods: 
Acute ICH patients were recruited to undergo multiparametric magnetic resonance 
imagingMRI (including dynamic contrast enhanced measurement of blood-brain barrier 
transfer constant (Ktrans) and positron emission tomography (PET) with [11C]-(R)-PK11195. 
[11C]-(R)-PK11195 binds to the translocator protein 18 kDa (TSPO), which is rapidly 
upregulated in activated microglia. Circulating inflammatory markers were measured at the 
time of PET. 
Results: 
Five patients were recruited to this feasibility study with imaging performed between 5 and 
16 days after onset. Etiologies included hypertension-related small vessel disease, cerebral 
amyloid angiopathy (CAA), cavernoma and arteriovenous malformation (AVM). [11C]-(R)-
PK11195 binding was low in all hematomas and two (patient 2 (probable CAA) and patient 4 
(AVM)) showed widespread increase in binding in the perihematomal region vs. 
contralateral. All had increased K
trans









) vs. contralateral. Two cases (patients 1 (cavernoma) and 4 
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(AVM)) had delayed surgery (three and 12-months post-onset, respectively) with biopsies 
showing intense microglial activation in perilesional tissue. 
Conclusions: 
Our study demonstrates for the first time the feasibility of performing complex multi-
modality brain imaging for non-invasive monitoring of neuroinflammation for this severe 
stroke subtype. These techniques will be useful tools in developing anti-inflammatory 
treatments for clinical ICH.  
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After intracerebral hemorrhage (ICH), extravasation of blood leads to immediate physical 
tissue injury. Secondary damage ensues over hours and days, mediated by a cascade of 
molecular and cellular events involving the toxic effects of blood components and sterile 
inflammation.
1
[1]. Within hours of onset, microglia become activated taking on a pro-
inflammatory phenotype, releasing cytokines and chemokines that activate astrocytes and 
endothelial cells causing blood-brain barrier (BBB) breakdown (alongside the direct effects 
of the ICH), recruitment of circulating leukocytes, and exacerbation of perihematomal 
edema.
2
[2]. Previous clinical studies in ICH have largely focused on peripheral inflammatory 
markers showing associations between fever, elevated white blood cell count, interleukin-6 
(IL-6), C-reactive protein (CRP), and fibrinogen on admission and worse sub-acute and long-
term outcomes.3[3]. These clinical studies demonstrate the importance of the systemic 
inflammatory response, but provide no information on processes within the brain, where 
inflammation contributes directly to secondary injury. Given the growing interest in 
modulating inflammation in acute ICH and the failure in ischemic stroke to translate findings 
from animal models, a means of studying inflammation in the intact human brain after ICH is 
urgently required.   
Using advanced multimodality imaging, it is possible to estimate the extent and distribution 
of microglial activation and BBB breakdown.  When activated, microglia express the 
translocator protein 18 kDa (TSPO), normally present at very low levels in the central 
nervous system. [
11
C]-(R)-PK11195 binds to TSPO and has been used for positron emission 
tomography (PET) studies of acute ischemic stroke,
4
[4], but in vivo imaging of microglial 
activation in ICH has not been previously described. Using magnetic resonance imaging 
(MRI) and computed tomography (CT) dynamic contrast enhanced (DCE) techniques, two 
previous studies have quantified BBB breakdown after ICH.5,6[5, 6]. Combining this 
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C]-(R)-PK11195 PET will provide a more complete picture of the 
inflammatory response and allow an understanding of the extent that BBB breakdown co-
localizes with microglial activation with important implications for the delivery of an anti-
inflammatory drug to the brain. Our aim was to demonstrate the feasibility of combining 




Patients between 4 and 28 days after onset of acute, spontaneous ICH were recruited from 
Salford Royal NHS Foundation Trust (Salford, UK) between 05/12/12 and 28/03/2014, 
following appropriate approvals. We excluded patients if they had a contraindication to MRI, 
were pregnant or breast feeding, had significant renal impairment, had an acute neurosurgical 
procedure performed or planned or who were taking medications which were likely to 
interfere with [
11
C]-(R)-PK11195 binding. MRI was performed on a Philips 3 T Achieva 
scanner (Salford Royal Hospital) with an 8 channel head coil. PET scans were performed 
within 4 days of MRI on a High Resolution Research Tomograph (Siemens/CTI) PET 
scanner (Wolfson Molecular Imaging Centre, University of Manchester). Venous blood was 
collected at recruitment (where possible) and immediately prior to the PET scan for 
measurement of key inflammatory mediators (CRP, IL-6, interleukin-1 (IL-1); see online 
supplement for immunoassay methods).  
MRI included T1-weighted volumetric Fast Field Echo (T1-FFE) imaging, T2-weighted fluid 
attenuated inversion recovery (FLAIR) imaging and T1-weighted DCE-MRI. Parametric 
maps of the blood-brain barrier transfer constant (K
trans
) were generated from DCE-MRI data 
using an uptake model (details of MRI acquisition and analysis in online supplementary 
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methods). PET data were analyzed as previously described.
7
[7]. In brief, iterative ordered 
subset expectation maximization 3D method was used to reconstruct a quantitative series of 
dynamic images from the 60 min PET emission scan. A reference tissue input function was 
extracted from cerebellar grey matter in order to generate parametric maps of binding 
potential BPND using the simplified reference tissue model. Using SPM (version 8), all maps 
and images were co-registered to the T1-weighted volume MRI. The T1-weighted volume 
image was segmented into grey matter and white matter probability maps and a maximum 
probability brain atlas8[8] was warped in to individual space. Two regions of interest (ROI) 
were defined manually from the T1-weighted and FLAIR images, representing hematoma and 
perihematomal edema. Corresponding ROIs in the contralateral brain region were generated 
by flipping the ipsilateral ROIs about the midline in the axial plane excluding any non-brain 




 within each ROI 
was then extracted from the parametric maps using Analyze version 12.0 (Mayo Clinic). 
 
Results 
Five patients with acute ICH underwent research brain imaging between 5 and 25 days after 
onset as part of this feasibility study (Table 1). All patients tolerated the scans without 
difficulty except patient 3, who was unable to complete the last 22 min of the 60 min 
emission PET scan and was the only one to undergo both scans on one day. Etiologies  
confirmed using appropriate clinical imaging included a cavernous angioma, an arteriovenous 
malformation (Figure 1), probable cerebral amyloid angiopathy and small vessel disease due 
to chronic hypertension. [11C]-(R)-PK11195 binding was low in all hematomas. Patients 2 & 
4 showed increased [
11
C]-(R)-PK11195 binding both within the perihematomal edema 
volume (0.24 and 0.06 respectively, vs. contralateral) and the ipsilateral brain region (0.13 & 
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0.12 respectively, vs. contralateral; Figure 2).  Patients 1 and 4 underwent surgery at 3 and 12 
months, respectively, with perlesional tissue demonstrating intense microglial activation. 
Analyses of DCE-MRI data show increases in Ktrans in the perihematomal edema volume 








) in all 5 patients relative to the 
contralateral. Visual inspection of images (Figure 2) consistently demonstrates a clear ring of 
increased K
trans
 adjacent to the outer border of the hematoma. No pattern is suggested for a 
relationship between circulating inflammatory markers and imaging., though for all cases, 
CRP was lower at the time of PET scanning than at recruitment. 
 
Discussion 
Our small study is the first to show imaging of microglial activation with PET after ICH and 
demonstrates the feasibility of performing complex multimodality brain imaging after acute 
ICH. However, we found that performing PET and MR scans on different days may improve 
successful study completion. All patients show clear ring-shaped BBB breakdown in the 
outer border of the hematoma, suggesting that delivery of treatments with limited transfer 
across the intact BBB may be enhanced in acute ICH. We observed a heterogeneous pattern 
of [
11
C]-(R)-PK11195 binding, with only two patients demonstrating enhanced binding 
around the hematoma. In neither case was the binding closely co-located with the BBB 
disruption, suggesting that factors other than microglial activation may drive BBB 
breakdown after ICH, an observation that should be investigated further in future studies. 
Late perilesional biopsies in two patients did show intense microglial activation, but only one 
had enhanced [
11
C]-(R)-PK11195 binding acutely. The long delay between PET and biopsies 
makes it difficult to interpret this disparity.  
 
Summary/Conclusions 
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We have demonstrated the feasibility of performing complex multimodality imaging to track 
the inflammatory response after ICH. This will be a vital tool in investigating this promising 
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Table 1. Baseline characteristics, inflammatory markers and imaging data.   
 Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 
Baseline Characteristics       
Age (years) 30 63 85 43 46 
Sex Female Male Female Male Male 
GCS at presentation 14 15 15 14 15 













ICH location Right 
temporal 
Right occipital Left cerebellar Left parietal Left lentiform 
ICH volume (ml) 6.1 6.7 8.5 30.0 7.1 
PHE volume (ml) 4.3 6.9 5.2 15.9 4.4 
PET scan (days post-onset) 7 11 25 16 10 
MR scan (days post-onset) 9 10 25 12 7 
Inflammatory mediators       
IL-1β      
    baseline (pg/ml) - - 0.56 0.63 0.81 
    PET scan  (pg/ml) 0.81 1.07 1.90 1.94 2.01 
IL-6      
    baseline (pg/ml) - - 7.77 2.35 2.73 
    PET scan  (pg/ml) 3.82 <0.012 4.29 1.5 4.47 
IL-8      
    baseline (pg/ml) - - 16.97 16.12 35.16 
    PET scan  (pg/ml) 11.53 4.84 15.77 10.66 25.59 
CRP      
    baseline (mg/l) - - 2.80 4.32 4.54 
    PET scan (mg/l) 0.472 0.598 0.862 0.85 1.64 
DCE-MRI parameters      
Mean Ktrans (x 10-3 min-1)      
   Perihematomal edema      
      Ipsilateral 1.8 5.7 2.1 2.9 2.2 
      Contralateral 0.4 0.7 1.0 1.0 0.6 
      Ipsilateral - contralateral 1.4 5.0 1.0 1.9 1.6 
Table 1: Baseline characteristics, inflammatory markers and imaging data. 
1
Based on 
modified Boston criteria; 
2
Confirmed on histology at later surgical resection. ICH = 
intracerebral haemorrhage, pg = picogram, ml = millilitre, l = litre, mg = milligram, GCS = 
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Glasgow Coma Scale,  PHE = peri-haematomal edema, CRP = C-reactive protein, DCE = 
dynamic contrast-enhanced, Ktrans = volume transfer constant, IL = interleukin, CAA = 
cerebral amyloid angiopathy. 
 
Figure legends 
Figure 1: Cluster of differentiation 68CD68 immunostaining (original magnification x400) 
demonstrates diffuse microglial activation (2a) in patient 1 (suspected cavernoma) and 
activated microglia and phagocytic activity (2b) in patient 4 (arteriovenous 
malformationAVM). 
 
Figure 2: Representative parametric maps of [
11
C]-(R)-PK11195 PET binding potential 
(BPND) (superimposed on to T1-weighted images) and volume transfer constant (K
trans ) with 
Fluid-attenuated inversion recovery (FLAIR) FLAIR images from each patient with regions 
of interestROIs for hematoma (green) and edema (red). Increased [11C]-(R)-PK11195 binding 
is indicated in patients 2&4 by arrows. 
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Cluster of differentiation 68 immunostaining (original magnification x400) demonstrates diffuse microglial 
activation (2a) in patient 1 (suspected cavernoma) and activated microglia and phagocytic activity (2b) in 
patient 4 (arteriovenous malformation).  
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Representative parametric maps of [11C]-(R)-PK11195 PET binding potential (BPND) (superimposed on to 
T1-weighted images) and volume transfer constant (Ktrans) with Fluid-attenuated inversion recovery 
(FLAIR) images from each patient with regions of interest for hematoma (green) and edema (red). 
Increased [11C]-(R)-PK11195 binding is indicated in patients 2&4 by arrows.  
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